Literature DB >> 27304843

Automated Light- and Dark-Adapted Perimetry for Evaluating Retinitis Pigmentosa: Filling a Need to Accommodate Multicenter Clinical Trials.

David B McGuigan, Alejandro J Roman, Artur V Cideciyan, Rodrigo Matsui, Michaela L Gruzensky, Rebecca Sheplock, Samuel G Jacobson.   

Abstract

PURPOSE: The purpose of this study was to develop a convenient means to measure rod (and cone) function by automated perimetry in patients with inherited retinal degenerations (IRDs).
METHODS: A currently available automated perimeter was used to determine sensitivity (in decibels) to a blue target in the dark-adapted (DA) state and a white target in the light-adapted (LA) state. Normal subjects and IRD patients were evaluated with a full-threshold 71-locus strategy (the retinitis pigmentosa [RP] test) and a size III target. Comparisons were made with results from the more commonly used methods of two-color DA perimetry and middle/long-wavelength LA perimetry in the same patients.
RESULTS: Rod function using the blue target and the RP test was determined for normal subjects by measuring DA sensitivities. If patients detected the blue stimulus in the DA state, it was determined whether the value was rod mediated by using normal data acquired during the cone plateau phase of dark adaptation. If rod mediated, rod sensitivity loss (RSL) was calculated and mapped across the visual field. Light-adapted sensitivities in normal subjects were also measured, permitting cone sensitivity losses (CSL) to be calculated for the patients. Multiple methods were used to compare RSL and CSL results with those from two-color DA perimetry and chromatic LA perimetry, and there was close correspondence between the methods.
CONCLUSIONS: The unmodified automated static perimeter used in the DA and LA states presents a practical approach to accomplish current goals of treatment trials in IRDs. This proof-of-principle study is an initial step toward establishing a clinical method to gather reproducible data on photoreceptor-mediated sensitivity.

Entities:  

Mesh:

Year:  2016        PMID: 27304843     DOI: 10.1167/iovs.16-19302

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  12 in total

1.  Effect of Oral Valproic Acid vs Placebo for Vision Loss in Patients With Autosomal Dominant Retinitis Pigmentosa: A Randomized Phase 2 Multicenter Placebo-Controlled Clinical Trial.

Authors:  David G Birch; Paul S Bernstein; Alessandro Iannacone; Mark E Pennesi; Byron L Lam; John Heckenlively; Karl Csaky; Mary Elizabeth Hartnett; Kevin L Winthrop; Thiran Jayasundera; Dianna K Hughbanks-Wheaton; Judith Warner; Paul Yang; Gary Edd Fish; Michael P Teske; Neal L Sklaver; Laura Erker; Elvira Chegarnov; Travis Smith; Aimee Wahle; Paul C VanVeldhuisen; Jennifer McCormack; Robert Lindblad; Steven Bramer; Stephen Rose; Patricia Zilliox; Peter J Francis; Richard G Weleber
Journal:  JAMA Ophthalmol       Date:  2018-08-01       Impact factor: 7.389

2.  Measurement of dark adaptometry during ISCEV standard flash electroretinography.

Authors:  Jeff Rabin; Brooke Houser; Carolyn Talbert; Rue Patel
Journal:  Doc Ophthalmol       Date:  2017-10-03       Impact factor: 2.379

3.  Variegated yet non-random rod and cone photoreceptor disease patterns in RPGR-ORF15-associated retinal degeneration.

Authors:  Jason Charng; Artur V Cideciyan; Samuel G Jacobson; Alexander Sumaroka; Sharon B Schwartz; Malgorzata Swider; Alejandro J Roman; Rebecca Sheplock; Manisha Anand; Marc C Peden; Hemant Khanna; Elise Heon; Alan F Wright; Anand Swaroop
Journal:  Hum Mol Genet       Date:  2016-12-15       Impact factor: 6.150

Review 4.  Clinical Perspective: Treating RPE65-Associated Retinal Dystrophy.

Authors:  Albert M Maguire; Jean Bennett; Elena M Aleman; Bart P Leroy; Tomas S Aleman
Journal:  Mol Ther       Date:  2020-12-03       Impact factor: 11.454

5.  Dark-Adapted Chromatic Perimetry for Measuring Rod Visual Fields in Patients with Retinitis Pigmentosa.

Authors:  Lea D Bennett; Martin Klein; Kirsten G Locke; Kelly Kiser; David G Birch
Journal:  Transl Vis Sci Technol       Date:  2017-08-09       Impact factor: 3.283

6.  Perspectives on Gene Therapy: Choroideremia Represents a Challenging Model for the Treatment of Other Inherited Retinal Degenerations.

Authors:  Ian M MacDonald; Christopher Moen; Jacque L Duncan; Stephen H Tsang; Jasmina Cehajic-Kapetanovic; Tomas S Aleman
Journal:  Transl Vis Sci Technol       Date:  2020-02-14       Impact factor: 3.283

7.  Photoreceptor-Specific Loss of Perifoveal Temporal Contrast Sensitivity in Retinitis Pigmentosa.

Authors:  Cord Huchzermeyer; Julien Fars; Jan Kremers
Journal:  Transl Vis Sci Technol       Date:  2020-05-27       Impact factor: 3.283

8.  Rod function deficit in retained photoreceptors of patients with class B Rhodopsin mutations.

Authors:  Artur V Cideciyan; Samuel G Jacobson; Alejandro J Roman; Alexander Sumaroka; Vivian Wu; Jason Charng; Brianna Lisi; Malgorzata Swider; Gustavo D Aguirre; William A Beltran
Journal:  Sci Rep       Date:  2020-07-28       Impact factor: 4.379

9.  Functionally validated imaging endpoints in the Alabama study on early age-related macular degeneration 2 (ALSTAR2): design and methods.

Authors:  Christine A Curcio; Gerald McGwin; Srinivas R Sadda; Zhihong Hu; Mark E Clark; Kenneth R Sloan; Thomas Swain; Jason N Crosson; Cynthia Owsley
Journal:  BMC Ophthalmol       Date:  2020-05-19       Impact factor: 2.209

10.  Repeatability of Scotopic Sensitivity and Dark Adaptation Using a Medmont Dark-Adapted Chromatic Perimeter in Age-related Macular Degeneration.

Authors:  Durin Uddin; Brett G Jeffrey; Oliver Flynn; Wai Wong; Henry Wiley; Tiarnan Keenan; Emily Chew; Catherine Cukras
Journal:  Transl Vis Sci Technol       Date:  2020-06-25       Impact factor: 3.283

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.